BR112016011096A2 - Aplicação de laminina à cultura de célula endotelial da córnea - Google Patents

Aplicação de laminina à cultura de célula endotelial da córnea

Info

Publication number
BR112016011096A2
BR112016011096A2 BR112016011096A BR112016011096A BR112016011096A2 BR 112016011096 A2 BR112016011096 A2 BR 112016011096A2 BR 112016011096 A BR112016011096 A BR 112016011096A BR 112016011096 A BR112016011096 A BR 112016011096A BR 112016011096 A2 BR112016011096 A2 BR 112016011096A2
Authority
BR
Brazil
Prior art keywords
corneal endothelial
present
laminin
cell culture
endothelial cells
Prior art date
Application number
BR112016011096A
Other languages
English (en)
Portuguese (pt)
Inventor
Koizumi Noriko
Okumura Naoki
Kinoshita Shigeru
E Kruse Friedrich
SCHLOETZER-SCHREHARDT Ursula
Original Assignee
Kyoto Prefectural Public Univ Corp
The Doshisha
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto Prefectural Public Univ Corp, The Doshisha, Senju Pharma Co filed Critical Kyoto Prefectural Public Univ Corp
Publication of BR112016011096A2 publication Critical patent/BR112016011096A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR112016011096A 2013-11-27 2014-11-26 Aplicação de laminina à cultura de célula endotelial da córnea BR112016011096A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013244972 2013-11-27
PCT/JP2014/081917 WO2015080297A1 (en) 2013-11-27 2014-11-26 Application of laminin to corneal endothelial cell culture

Publications (1)

Publication Number Publication Date
BR112016011096A2 true BR112016011096A2 (pt) 2017-09-19

Family

ID=52432880

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016011096A BR112016011096A2 (pt) 2013-11-27 2014-11-26 Aplicação de laminina à cultura de célula endotelial da córnea

Country Status (10)

Country Link
US (1) US11624053B2 (enExample)
EP (1) EP3074508B1 (enExample)
JP (3) JP6470286B2 (enExample)
CN (1) CN105814195A (enExample)
BR (1) BR112016011096A2 (enExample)
CA (1) CA2931280A1 (enExample)
ES (1) ES2763433T3 (enExample)
MX (1) MX2016006915A (enExample)
RU (1) RU2704984C1 (enExample)
WO (1) WO2015080297A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20190460T1 (hr) 2011-12-06 2019-04-19 Astellas Institute For Regenerative Medicine Postupak proizvodnje endotelnih stanica rožnice usmjerenom diferencijacijom
EP3213761B1 (en) 2014-10-31 2021-05-19 Kyoto Prefectural Public University Corporation Novel treatment of retina using laminin
BR112017008805A2 (pt) 2014-10-31 2017-12-19 Kyoto Prefectural Public Univ Corp tratamento de córnea usando laminina
JP6849957B2 (ja) * 2015-11-10 2021-03-31 国立大学法人京都大学 ラミニンフラグメント含有培地を用いる細胞培養方法
EP3375860A4 (en) 2015-11-10 2019-07-03 Nikkiso Co., Ltd. CELL SUPPORT COMPOSITE AND METHOD FOR PRODUCING THE CELL SUPPORT COMPOSITE
WO2018143312A1 (ja) * 2017-01-31 2018-08-09 国立大学法人大阪大学 多能性幹細胞の分化制御方法
WO2019079809A1 (en) * 2017-10-22 2019-04-25 The Johns Hopkins University BIOMIMETIC PLATFORMS FOR MODELING VASCULAR PHYSIOPATHOLOGY, DIAGNOSIS AND THERAPY
WO2019102593A1 (ja) * 2017-11-24 2019-05-31 株式会社Ihi 細胞培養装置
JP6664755B1 (ja) * 2018-10-02 2020-03-13 学校法人同志社 角膜内皮細胞を保存するための方法および容器
CN113015429A (zh) * 2018-10-02 2021-06-22 学校法人同志社 用于保存角膜内皮细胞的方法和容器
US20220133659A1 (en) * 2019-03-12 2022-05-05 Nissan Chemical Corporation Therapeutic agent for corneal diseases
JP2023025311A (ja) * 2020-02-05 2023-02-22 味の素株式会社 タンパク質の製造方法
CN112522179A (zh) * 2020-12-23 2021-03-19 江苏艾尔康生物医药科技有限公司 一种角膜内皮细胞的分离培养方法

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678783B1 (en) 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
EP1195372A1 (en) 1994-04-18 2002-04-10 Mitsubishi Pharma Corporation N-heterocyclic substituted benzamide derivatives with antihypertensive activity
JP3421217B2 (ja) 1995-11-20 2003-06-30 麒麟麦酒株式会社 Ｒｈｏ標的タンパク質Ｒｈｏキナーゼ
EP0954328A4 (en) 1996-06-05 2002-07-17 Gen Hospital Corp Laminin-5 and the production of a basement membrane structure
FR2765781B1 (fr) 1997-07-08 1999-09-24 Gioia Bruno Di Procede de fabrication d'un accessoire de mode, dispositif pour la mise en oeuvre du procede et accessoire de mode ainsi realise
US6042262A (en) 1997-07-29 2000-03-28 Stryker Technologies Corportion Apparatus for storing, mixing, and dispensing two-component bone cement
US6693169B1 (en) 1998-10-13 2004-02-17 The General Hospital Corporation Laminin 5, 13 and 14 and uses thereof
JP2002542824A (ja) 1999-04-30 2002-12-17 バイオストラタム インコーポレイテッド 組換えラミニン５
US6635616B2 (en) 2000-05-01 2003-10-21 The General Hospital Corporation Laminin 15
WO2002050111A2 (en) 2000-12-21 2002-06-27 Biostratum, Inc. Isolated laminin 10
MXPA03008659A (es) 2001-03-23 2005-04-08 Bayer Ag Inhibidores de rho-cinasa.
EP1370553B1 (en) 2001-03-23 2006-05-10 Bayer Corporation Rho-kinase inhibitors
CN101310771B (zh) 2001-04-11 2012-08-08 千寿制药株式会社 视觉功能障碍改善剂
EP1403255A4 (en) 2001-06-12 2005-04-06 Sumitomo Pharma RHO KINASE INHIBITORS
WO2003059913A1 (en) 2002-01-10 2003-07-24 Bayer Healthcare Ag Roh-kinase inhibitors
ATE381557T1 (de) 2002-01-23 2008-01-15 Bayer Pharmaceuticals Corp Rho-kinase inhibitoren
JP2004024852A (ja) 2002-04-30 2004-01-29 Amniotec:Kk 角膜内皮様シート、及びその作製方法
CA2483659A1 (en) * 2002-04-30 2003-11-13 Amniotec Inc. Corneal endothelium-like sheet and method of constructing the same
CN100354264C (zh) 2002-07-22 2007-12-12 旭化成制药株式会社 5－取代异喹啉衍生物及含有它们的药物
CA2400996A1 (en) 2002-09-03 2004-03-03 Lisa Mckerracher 1,4-substituted cyclohexane derivatives
US7160894B2 (en) 2003-06-06 2007-01-09 Asahi Kasei Pharma Corporation Tricyclic compound
CA2530389A1 (en) 2003-07-02 2005-01-13 Biofocus Discovery Limited Pyrazine and pyridine derivatives as rho kinase inhibitors
US20050182061A1 (en) 2003-10-02 2005-08-18 Jeremy Green Phthalimide compounds useful as protein kinase inhibitors
US7547779B2 (en) 2003-10-06 2009-06-16 Glaxo Group Limited Preparation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors
JP2007507547A (ja) 2003-10-06 2007-03-29 グラクソ　グループ　リミテッド キナーゼ阻害剤としての１，７−二置換アザベンゾイミダゾールの調製
JP2007507549A (ja) 2003-10-06 2007-03-29 グラクソ　グループ　リミテッド キナーゼ阻害剤としての１，６，７−三置換アザベンゾイミダゾールの調製
DK1675944T3 (da) 2003-10-10 2011-02-28 Ge Ming Lui Humane corneale endotelceller og fremgangsmåder til opnåelse og dyrkning af celler til corneal celletransplantation
CN100560142C (zh) * 2003-10-10 2009-11-18 细胞生物工程公司 用于在生物聚合物上培养角膜内皮细胞和相关细胞以及产生人工角膜移植物的方法和组合物
JP2007509643A (ja) 2003-10-10 2007-04-19 ゲ・ミン・ルイ 角膜内皮および関連細胞のバイオポリマー上での増殖のための方法および組成物ならびに人工角膜移植片の作成
JP2007008816A (ja) 2003-10-15 2007-01-18 Ube Ind Ltd 新規イソキノリン誘導体
JP2007015928A (ja) 2003-10-15 2007-01-25 Ube Ind Ltd 新規オレフィン誘導体
EP2468729B1 (en) 2003-10-15 2013-12-25 Ube Industries, Ltd. Novel indazole derivative
WO2005070011A2 (en) 2004-01-23 2005-08-04 Advanced Cell Technology, Inc. Improved modalities for the treatment of degenerative diseases of the retina
ES2532778T3 (es) 2004-02-12 2015-03-31 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Administración terapéutica del péptido antiangiogénico mezclado C16Y
CA2556589A1 (en) 2004-02-24 2005-09-01 Bioaxone Therapeutique Inc. 4-substituted piperidine derivatives
MXPA06011328A (es) 2004-04-02 2006-12-15 Vertex Pharma Azaindoles utiles como inhibidotes de roca y otras proteinas cinasas.
EP1829876A4 (en) 2004-11-26 2009-04-01 Asahi Kasei Pharma Corp NITROGENIC TRICYCLIC COMPOUND
US7618984B2 (en) 2005-08-30 2009-11-17 Asahi Kasei Pharma Corporation Sulfonamide compound
EP1980274B1 (en) 2006-01-19 2016-03-23 Senju Pharmaceutical Co., Ltd. Corneal endothelial preparation which enables cells to grow in vivo
US20090175835A1 (en) 2006-02-07 2009-07-09 Korea Institute Of Radiological & Medical Sciences Composition for treating damage of central or peripheral nerve system
WO2007127172A2 (en) 2006-04-27 2007-11-08 The Trustees Of Columbia University In The City Of New York Layered bio-adhesive compositions and uses thereof
US8951799B2 (en) 2007-01-04 2015-02-10 Biolamina Ab Composition and method for enabling proliferation of pluripotent stem cells
KR20240045364A (ko) 2007-08-29 2024-04-05 센주 세이야꾸 가부시키가이샤 각막 내피 세포 접착 촉진제
US20090306772A1 (en) 2008-04-18 2009-12-10 The Regents Of The University Of California Ocular Scaffolds and Methods for Subretinal Repair of Bruch's Membrane
US8680182B2 (en) 2009-06-04 2014-03-25 Clemson University Research Foundation Methods for promoting the revascularization and reenervation of CNS lesions
JP2011010653A (ja) 2009-06-05 2011-01-20 Kumamoto Univ 細胞の分化誘導方法
JP5590646B2 (ja) * 2009-10-08 2014-09-17 国立大学法人大阪大学 ヒト多能性幹細胞用培養基材およびその利用
RU2418067C1 (ru) 2009-12-03 2011-05-10 Государственное образовательное учреждение высшего профессионального образования "Оренбургский государственный университет" Способ культивирования клеток
WO2011080984A1 (en) 2009-12-29 2011-07-07 Senju Pharmaceutical Co., Ltd. Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction
BR112013017632A2 (pt) 2010-12-17 2016-10-11 Biolamina Ab meio de cultura celular
WO2012173207A1 (ja) 2011-06-14 2012-12-20 独立行政法人理化学研究所 網膜細胞への分化誘導方法
WO2013012087A1 (ja) * 2011-07-15 2013-01-24 国立大学法人大阪大学 角膜内皮細胞の調製方法
JPWO2013047763A1 (ja) 2011-09-29 2015-03-30 オリエンタル酵母工業株式会社 ラミニン５１１を含んだ系で哺乳類細胞を培養する方法
LT2780022T (lt) 2011-11-14 2019-07-10 Astellas Institute For Regenerative Medicine Žmogaus rpe ląstelių farmaciniai preparatai ir jų panaudojimas
JP5985207B2 (ja) 2011-11-25 2016-09-06 住友化学株式会社 網膜色素上皮細胞の製造方法
EP2784152B1 (en) 2011-11-25 2019-04-10 Sumitomo Chemical Company, Limited Methods for producing retinal tissue and retina-related cell
HRP20190460T1 (hr) * 2011-12-06 2019-04-19 Astellas Institute For Regenerative Medicine Postupak proizvodnje endotelnih stanica rožnice usmjerenom diferencijacijom
WO2013148377A1 (en) 2012-03-25 2013-10-03 The Board Of Trustees Of The Leland Stanford Junior University Methods for modulating hair growth using truncated laminin-511
WO2014087244A2 (en) 2012-12-03 2014-06-12 Biolamina Ab Methods of producing rpe cells
EP3056563B1 (en) 2013-10-09 2020-06-24 Healios K.K. Method of producing retinal pigment epithelial cell
EP3213761B1 (en) 2014-10-31 2021-05-19 Kyoto Prefectural Public University Corporation Novel treatment of retina using laminin
BR112017008805A2 (pt) 2014-10-31 2017-12-19 Kyoto Prefectural Public Univ Corp tratamento de córnea usando laminina
WO2020006539A1 (en) 2018-06-29 2020-01-02 Platelet Biogenesis, Inc. Compositions for drug delivery and methods of use thereof

Also Published As

Publication number Publication date
WO2015080297A1 (en) 2015-06-04
JP2016539641A (ja) 2016-12-22
JP2019054828A (ja) 2019-04-11
ES2763433T3 (es) 2020-05-28
CN105814195A (zh) 2016-07-27
JP2020188778A (ja) 2020-11-26
EP3074508B1 (en) 2019-11-06
US11624053B2 (en) 2023-04-11
MX2016006915A (es) 2017-01-23
EP3074508A1 (en) 2016-10-05
CA2931280A1 (en) 2015-06-04
JP6470286B2 (ja) 2019-02-13
RU2016125225A (ru) 2018-01-09
US20170002318A1 (en) 2017-01-05
RU2704984C1 (ru) 2019-11-01

Similar Documents

Publication Publication Date Title
BR112016011096A2 (pt) Aplicação de laminina à cultura de célula endotelial da córnea
AR090465A1 (es) Formas solidas de un profarmaco de nucleotidos de tiofosforamidato
BR112015001620A2 (pt) composição de meio de cultura, e método para cultivo de célula ou tecido usando-se dita composição
BR112015022545A2 (pt) compostos de pirazolo e os usos disso
BR112012030197A2 (pt) diminuição do nível de lactato e aumento da produção de poliptídeo por subregulação da expressão de lactato desidrogenase e piruvato desidrogenase cinase.
BR112017013599A2 (pt) composição farmacêutica, e, método para prevenir, tratar ou melhorar um ou mais sintomas de um tumor maligno associado à mutação de kras.
BR112016025331A2 (pt) composições antimicrobianas
BR112017005378A2 (pt) composições que compreendem células recombinantes de bacillus e um outro agente de controle biológico.
BR112014030007A2 (pt) minivetores superenrolados como uma ferramenta para reparação, alteração e substituição de dna
MX2020002867A (es) Inhibidores de glucosilceramida sintasa.
BR112015007448A2 (pt) processo para preparar um amido inibido
BR112014030812A2 (pt) "compostos tricíclicos substituídos como inibidores de fgfr, seus usos, composição farmacêutica e método para inibir uma enzima fgfr"
MX2016003486A (es) Inhibidores de glucosilceramida sintasa para el tratamiento de enfermedades.
BR112017006469A2 (pt) composições e métodos para inibição de expressão do gene hao1 (hidroxiácido oxidase 1 (glicolato oxidase))
CR20180503A (es) Composiciones y métodos para programar células terapéuticas utilizando nanoportadores de ácidos nucleicos dirigidos
BR112014026740A2 (pt) anticorpo, composição, métodos para tratar um mamífero e para fornecer um anticorpo com adcc realçada, e, uso de um anticorpo
BR112017013394A2 (pt) fabricação de proteína
BR112015009229A2 (pt) composição tendo como alvo a expressão de genes para plaquetas, célula tronco hematopoiética, uso da referida célula tronco e método in vitro ou ex vivo para gerar uma célula tronco modificada
CA2863600A1 (en) Modulators of acyl-coa lysocardiolipin acyltransferase 1 ( alcat1) and uses thereof
BR112016017509A2 (pt) composições e métodos compreendendo uma variante da enzima xilanase
BR112015002295A2 (pt) métodos e composições para indução in vivo de formação de célula beta pancreática
BR112016007562A2 (pt) interferência com repressão do fator de transcrição hd-zip de expressão gênica para produzir plantas com traços intensificados
BR112015014367A2 (pt) formulações inibidoras de lfa-1
BR112017013576A2 (pt) produção melhorada de lipídios de núcleo em leveduras oleaginosas
MX2016008258A (es) Celulas eucariotas novedosas y metodos para la expresion recombinante de un producto de interes.

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION (J

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements